Arvinas holder plans Rule 144 sale of 4,592 shares

A shareholder of Arvinas, Inc. has filed a notice to sell 4,592 common shares under Rule 144.

Rhea-AI Filing Summary

A shareholder of Arvinas, Inc. has filed a notice to sell 4,592 common shares under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of 54607.52. The issuer had 64224294 shares outstanding, and the approximate sale date is 02/13/2026.

The securities were acquired on 02/13/2026 through settlement of vested restricted stock units from Arvinas, Inc., with payment also dated 02/13/2026 and described as not applicable, indicating no separate cash purchase at that time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for Arvinas (ARVN) disclose?

The filing discloses that a shareholder intends to sell 4,592 Arvinas common shares under Rule 144. The shares are to be sold on NASDAQ through Morgan Stanley Smith Barney LLC, with an aggregate market value reported as 54607.52.

How many Arvinas (ARVN) shares are covered by this planned Rule 144 sale?

The notice covers 4,592 common shares of Arvinas, Inc. to be sold. These shares are listed with an aggregate market value of 54607.52 and are to be transacted on NASDAQ through Morgan Stanley Smith Barney LLC as the broker.

When are the Arvinas (ARVN) shares expected to be sold under this Form 144?

The approximate date of sale is listed as 02/13/2026. On that date, 4,592 common shares are planned for sale on NASDAQ, with Morgan Stanley Smith Barney LLC acting as the broker for the transaction.

How were the Arvinas (ARVN) shares being sold under Rule 144 acquired?

The 4,592 common shares were acquired on 02/13/2026 through settlement of vested restricted stock units from Arvinas, Inc. The filing describes the nature of payment as not applicable, indicating no separate cash payment at acquisition.

What is the reported market value of the Arvinas (ARVN) shares in this Form 144?

The filing reports an aggregate market value of 54607.52 for the 4,592 common shares to be sold. This value reflects the total market amount associated with the planned Rule 144 sale on NASDAQ through Morgan Stanley Smith Barney LLC.

How many Arvinas (ARVN) shares were outstanding relative to this Form 144 sale?

The issuer had 64224294 common shares outstanding according to the filing. The planned Rule 144 sale covers 4,592 of those shares, which are to be sold on NASDAQ with Morgan Stanley Smith Barney LLC as the broker.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 05:00 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002026306
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Arvinas Inc
SEC File Number	001-38672
Address of Issuer	396 Winchester Ave. 5 Science Park New Haven CONNECTICUT 06511
Phone	4753453828
Name of Person for Whose Account the Securities are To Be Sold	Angela Cacace
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza New York NY 100004	4592	54607.52	64224294	02/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2026	Settlement of vested restricted stock units	Arvinas, Inc			4592	02/13/2026	Not applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The sale reported on this Form 144 was made automatically to cover withholding taxes following the vesting of previously granted restricted stock units. The sale does not represent a discretionary trade.
Date of Notice	02/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christina Bailey, as attorney-in-fact for Angela Cacace
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)